Neuroscientific Biopharmaceuticals Ltd Asset Resilience Ratio

Latest as of December 2025: 38.16%

Neuroscientific Biopharmaceuticals Ltd asset resilience ratio. Neuroscientific Biopharmaceuticals Ltd (NSB) has an Asset Resilience Ratio of 38.16% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See NSB days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

AU$6.36 Million

≈ $4.50 Million USD Cash + Short-term Investments

Total Assets

AU$16.66 Million

≈ $11.79 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Neuroscientific Biopharmaceuticals Ltd (2019–2025)

Asset resilience ratio of Neuroscientific Biopharmaceuticals Ltd from 2019 to 2025. This chart shows how Neuroscientific Biopharmaceuticals Ltd's Asset Resilience Ratio has changed over time. Read how much debt does Neuroscientific Biopharmaceuticals Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Neuroscientific Biopharmaceuticals Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Neuroscientific Biopharmaceuticals Ltd's balance sheet.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$1.11 Million	6.65%
Short-term Investments	AU$5.25 Million	31.51%
Total Liquid Assets	AU$6.36 Million	38.16%

Asset Resilience Insights

Very High Liquidity: Neuroscientific Biopharmaceuticals Ltd maintains exceptional liquid asset reserves at 38.16% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Neuroscientific Biopharmaceuticals Ltd Industry Peers by Asset Resilience Ratio

Compare Neuroscientific Biopharmaceuticals Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Xizang Haisco Pharmaceutical Group Co Ltd SHE:002653	Biotechnology	1.69%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Definium Therapeutics, Inc. NASDAQ:DFTX	Biotechnology	38.51%
Beijing Wantai Biological Pharmacy Enterprise Co Ltd SHG:603392	Biotechnology	11.40%
BB Biotech AG SW:BION	Biotechnology	92.97%
Zealand Pharma A/S CO:ZEAL	Biotechnology	63.98%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%

Neuroscientific Biopharmaceuticals Ltd Asset Resilience Ratio by Year (2019–2025)

Neuroscientific Biopharmaceuticals Ltd asset resilience ratio by year from 2019 to 2025. The table below shows the annual Asset Resilience Ratio data for Neuroscientific Biopharmaceuticals Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	42.83%	AU$7.27 Million ≈ $5.14 Million	AU$16.96 Million ≈ $12.00 Million	-48.30pp
2024-06-30	91.14%	AU$4.95 Million ≈ $3.51 Million	AU$5.44 Million ≈ $3.85 Million	-1.69pp
2023-06-30	92.83%	AU$4.91 Million ≈ $3.48 Million	AU$5.29 Million ≈ $3.74 Million	-0.43pp
2022-06-30	93.26%	AU$7.22 Million ≈ $5.11 Million	AU$7.74 Million ≈ $5.47 Million	-2.25pp
2021-06-30	95.51%	AU$14.16 Million ≈ $10.02 Million	AU$14.83 Million ≈ $10.49 Million	+7.58pp
2020-06-30	87.94%	AU$3.29 Million ≈ $2.33 Million	AU$3.74 Million ≈ $2.64 Million	-2.04pp
2019-06-30	89.97%	AU$4.61 Million ≈ $3.26 Million	AU$5.12 Million ≈ $3.63 Million	--

pp = percentage points

About Neuroscientific Biopharmaceuticals Ltd

AU:NSB Australia Biotechnology

Market Cap

$12.71 Million

AU$17.96 Million AUD

Market Cap Rank

#26298 Global

#1177 in Australia

Share Price

AU$0.05

Change (1 day)

+3.85%

52-Week Range

AU$0.05 - AU$0.17

All Time High

AU$0.52